• Company
• Entresto faces competition in the heart failure market
• by Moon, sung-ho Aug 19, 2024 05:47am

• Company
• Twice-yearly Uplizna enters last stage to reimb in KOR
• by Eo, Yun-Ho Aug 16, 2024 05:56am

• Company
• OraTicx signs a distribution deal with U.S.-based Stratum
• by Son, Hyung-Min Aug 16, 2024 05:56am

• Company
• K-Pharma speeds up marketing new drugs for bile duct cancer
• by Son, Hyung-Min Aug 16, 2024 05:55am

• Company
• LG Chem begins Phase 2 trials for infant hexavalent vaccine
• by Hwang, Byung-woo Aug 14, 2024 05:51am

• Company
• 'Xtandi and Erleada' compete in the prostate cancer market
• by Hwang, Byung-woo Aug 14, 2024 05:51am

• Company
• Nabota accounts for 24% of Daewoong’s ETC sales
• by Chon, Seung-Hyun Aug 13, 2024 05:47am

• Company
• 'High immunity vs. high dose’ flu vaccine for older adults
• by Hwang, Byung-woo Aug 13, 2024 05:47am

• Company
• Hanmi’s Rolvedon posts sales of KRW 20.6 billion in Q2
• by Son, Hyung-Min Aug 13, 2024 05:47am

• Company
• JAK inhibitors market size rose 54%↑over the year
• by Kim, Jin-Gu Aug 12, 2024 05:55am